TNF and Sepsis: Despite potential validity and utility of markers for sepsis IP, such as human leukocyte antigen-DR (HLA-DR), tumor necrosis factor (TNF)-α, or absolute lymphocyte counts (ALC), the CARS paradigm faces 2 fundamental challenges (3, 4, 28, 35).